Sweet SIGNs: IgG glycosylation leads the way in IVIG-mediated resolution of inflammation

Beitrag in einer Fachzeitschrift


Details zur Publikation

Autor(en): Brückner C, Lehmann C, Dudziak D, Nimmerjahn F
Zeitschrift: International Immunology
Jahr der Veröffentlichung: 2017
Band: 29
Heftnummer: 11
Seitenbereich: 499-509
ISSN: 0953-8178


Abstract

A hallmark of many chronic inflammatory and autoimmune diseases is that there is an impaired resolution of inflammation and return to the steady state. The infusion of high doses of pooled serum IgG preparations from thousands of donors [intravenous immunoglobulin (IVIG) therapy] has been shown to induce resolution of inflammation in a variety of chronic inflammatory and autoimmune diseases, suggesting that IgG molecules can instruct the immune system to stop inflammatory processes and initiate the return to the steady state. The aim of this review is to discuss how insights into the mechanism of IVIG activity may help to understand the molecular and cellular pathways underlying resolution of inflammation. We will put a special emphasis on pathways dependent on the IgG FC domain and IgG sialylation, as several recent studies have provided new insights into how this glycosylation-dependent pathway modulates innate and adaptive immune responses through different sets of C-type or I-type lectins.


FAU-Autoren / FAU-Herausgeber

Brückner, Christin
Lehrstuhl für Genetik
Dudziak, Diana Prof. Dr.
Professur für die Biologie Dendritischer Zellen
Lehmann, Christian Dr. rer. nat.
Hautklinik
Nimmerjahn, Falk Prof. Dr.
Lehrstuhl für Genetik


Zitierweisen

APA:
Brückner, C., Lehmann, C., Dudziak, D., & Nimmerjahn, F. (2017). Sweet SIGNs: IgG glycosylation leads the way in IVIG-mediated resolution of inflammation. International Immunology, 29(11), 499-509. https://dx.doi.org/10.1093/intimm/dxx053

MLA:
Brückner, Christin, et al. "Sweet SIGNs: IgG glycosylation leads the way in IVIG-mediated resolution of inflammation." International Immunology 29.11 (2017): 499-509.

BibTeX: 

Zuletzt aktualisiert 2018-16-11 um 19:08